0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
The committee, in its report, has mentioned that the present stock-inhand of the APIs may be sufficient for 2 to 3 months to manufacture formulations and also given certain recommendations. The committee further mentioned that there is no need to panic so far as drug security is concerned.
Share this article
If you liked this article share it with your friends.they will thank you later